Integra LifeSciences Holdings Asset Resilience Ratio
Integra LifeSciences Holdings asset resilience ratio. Integra LifeSciences Holdings (IART) has an Asset Resilience Ratio of 0.80% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See IART defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Integra LifeSciences Holdings (1999–2025)
Asset resilience ratio of Integra LifeSciences Holdings from 1999 to 2025. This chart shows how Integra LifeSciences Holdings's Asset Resilience Ratio has changed over time. Read Integra LifeSciences Holdings debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Integra LifeSciences Holdings's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Integra LifeSciences Holdings asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $28.69 Million | 0.8% |
| Total Liquid Assets | $28.69 Million | 0.80% |
Asset Resilience Insights
- Limited Liquidity: Integra LifeSciences Holdings maintains only 0.80% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Integra LifeSciences Holdings Industry Peers by Asset Resilience Ratio
Compare Integra LifeSciences Holdings's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Integra LifeSciences Holdings Asset Resilience Ratio by Year (1999–2025)
Integra LifeSciences Holdings asset resilience ratio by year from 1999 to 2025. The table below shows the annual Asset Resilience Ratio data for Integra LifeSciences Holdings.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.80% | $28.69 Million | $3.60 Billion | +0.12pp |
| 2024-12-31 | 0.67% | $27.19 Million | $4.04 Billion | -0.19pp |
| 2023-12-31 | 0.86% | $32.69 Million | $3.78 Billion | +0.44pp |
| 2022-12-31 | 0.43% | $16.68 Million | $3.89 Billion | +0.43pp |
| 2019-12-31 | 0.00% | $12.00K | $3.30 Billion | -0.15pp |
| 2018-12-31 | 0.15% | $4.65 Million | $3.11 Billion | +0.10pp |
| 2017-12-31 | 0.05% | $1.52 Million | $3.21 Billion | +0.03pp |
| 2016-12-31 | 0.01% | $242.00K | $1.81 Billion | -0.22pp |
| 2015-12-31 | 0.23% | $4.07 Million | $1.77 Billion | -- |
| 2014-12-31 | 0.00% | $0.00 | $1.58 Billion | -- |
| 2013-12-31 | 0.00% | $0.00 | $1.20 Billion | -- |
| 2012-12-31 | 0.00% | $0.00 | $1.16 Billion | -- |
| 2011-12-31 | 0.00% | $0.00 | $1.14 Billion | -- |
| 2010-12-31 | 0.00% | $0.00 | $1.02 Billion | -- |
| 2005-12-31 | 17.91% | $80.33 Million | $448.43 Million | +11.14pp |
| 2004-12-31 | 6.78% | $30.95 Million | $456.71 Million | -0.39pp |
| 2003-12-31 | 7.17% | $29.57 Million | $412.53 Million | -12.96pp |
| 2002-12-31 | 20.13% | $55.28 Million | $274.67 Million | +10.38pp |
| 2001-12-31 | 9.75% | $22.18 Million | $227.59 Million | +8.53pp |
| 2000-12-31 | 1.22% | $1.05 Million | $86.51 Million | -5.27pp |
| 1999-12-31 | 6.49% | $4.30 Million | $66.30 Million | -- |
About Integra LifeSciences Holdings
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural … Read more